Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-400
Closed -$18K 1127
2021
Q2
$18K Buy
+400
New +$18.8K ﹤0.01% 758
2019
Q4
Sell
-43
Closed -$2K 967
2019
Q3
$2K Hold
43
﹤0.01% 912
2019
Q2
$2K Buy
+43
New +$1.5K ﹤0.01% 920

Other funds holding SNV

HM Payson & Co's SNV Position: Q3 2021 in Review

HM Payson & Co sold out of Synovus (SNV) in Q3 2021, closing a stake of 400 shares — an estimated $18K sold.

HM Payson & Co first reported a position in SNV in Q2 2019 and held it in 3 quarters. The position peaked at $18K in Q2 2021. 386 funds tracked by Wall St. Rank hold SNV as of Q3 2021.

  • HM Payson & Co reported no remaining Synovus position as of Q3 2021 after selling out during the quarter.
  • HM Payson & Co sold 400 Synovus shares in Q3 2021, an estimated $18K.
  • HM Payson & Co first reported a position in Synovus in Q2 2019 and held it in 3 quarters.
  • HM Payson & Co's Synovus position peaked at $18K in Q2 2021.
  • 386 funds tracked by Wall St. Rank held Synovus as of Q3 2021.

Based on HM Payson & Co's 13F filing for Q3 2021, filed 30 Nov 2021.